Ticker brief
BMEA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
12
authors 14d
10
crowd 14d
+0.28
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-24 → 2026-08-25 · now +0.40 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Briefingcom | B | +0.50 | 2 | +0.28 |
| @BiopharmIQ | B | · | 2 | +0.33 |
| @tenet_research | C | -0.96 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.30 |
| @OzmosiHealth | C | · | 1 | +0.20 |
| @OptionsFlowBoss | C | · | 1 | +0.45 |
| @zohmbastic | C | -1.38 | 1 | +0.15 |
| @BPharmCatalyst | C | · | 1 | +0.10 |
| @PrismMarketView | C | · | 1 | +0.35 |
| @Analytica_X | B | +1.03 | 1 | +0.40 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-25 | @Analytica_X | +0.40 | Lists five small-cap gainers and their one-day percentage moves, including a clinical enrollment catalyst. | · | tweet ↗ |
| 2026-08-24 | @PrismMarketView | +0.35 | Quantifies broad index declines and the session's largest individual-stock moves. | · | tweet ↗ |
| 2026-08-24 | @BPharmCatalyst | +0.10 | Biomea enrolled 64 Phase 2 participants with 26-week topline results expected in Q1 2027. | · | tweet ↗ |
| 2026-08-24 | @zohmbastic | +0.15 | Reports high relative volume exceeding 10 million shares. | · | tweet ↗ |
| 2026-08-24 | @BiopharmIQ | +0.35 | Summarizes four biotech regulatory or clinical catalysts and corresponding price moves. | · | tweet ↗ |
| 2026-08-24 | @BiopharmIQ | +0.30 | Dense biotech list reports trial, PDUFA, filing and approval developments with market moves. | · | tweet ↗ |
| 2026-08-24 | @OptionsFlowBoss | +0.45 | Lists unusual bullish options-volume multiples during the first two trading hours. | · | tweet ↗ |
| 2026-08-24 | @OzmosiHealth | +0.20 | Biomea completed enrollment in the COVALENT-211 Phase II trial. | · | tweet ↗ |
| 2026-08-24 | @OpenOutcrier | +0.30 | Biomea completed enrollment in its diabetes trial. | · | tweet ↗ |
| 2026-08-24 | @tenet_research | +0.00 | Premarket-movers watchlist with no direction or performance figures in the visible text. | · | tweet ↗ |
| 2026-08-24 | @Briefingcom | +0.25 | Biomea completed enrollment in its phase II COVALENT-211 trial. | · | tweet ↗ |
| 2026-08-24 | @Briefingcom | +0.30 | Lists premarket gap moves; limited to the first six tickers under the schema cap. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.